Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

New ACC/AHA/HFSA guideline redefines heart failure stages to focus on prevention, updates treatment options and emphasizes care coordination with a heart failure specialty team
News | Heart Failure
ACC, AHA, HFSA Issue Joint Heart Failure Guideline

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

Home April 01, 2022
Home
Philips Ambient Experience with FlexVision display for pediatric patients
News | ACC
Philips Adds to its Cardiology Suite of Solutions at ACC 2022

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Most Read Cardiology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal+, the next generation of the company’s PerQseal device.
News | Structural Heart
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+

March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home March 31, 2022
Home
HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic valve replacement (TAVR) therapy, announced today that it has received U.S. Food and Drug Administration (FDA) approval for two clinical studies to assess the performance and safety of its HLT Meridian TAVR Valve System to treat aortic stenosis and aortic regurgitation among high-risk patients suffering from aortic disease.
News | Structural Heart
HLT, Inc. Gains FDA Approval for Two TAVR Clinical Studies

March 24, 2022 — HLT Inc., a Bracco Group Company and a leader in the development of cutting edge transcatheter aortic ...

Home March 24, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
DAIC’s Top 10 for the Month of February

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of ...

Home March 04, 2022
Home
An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery.
News | Heart Valve Technology
Novel Technology Could Prevent Repeat Operations to Replace a Faulty Bioprosthetic Heart Valve

March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can ...

Home March 02, 2022
Home
TRIA valve
News | Heart Valve Technology
TRIA Transcatheter Biopolymer Heart Valve Shows Promise in Pilot Animal Study

February 28, 2022 - Foldax, Inc. has announced the presentation of results from the first animal study of its ...

Home February 28, 2022
Home
WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device
News | Left Atrial Appendage (LAA) Occluders
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real ...

Home February 28, 2022
Home
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
News | Endovascular Aortic Repair
Front Line Medical Technologies Expands Availability of its COBRA-OS

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
This study was evaluating 30-days and 1-year safety and performance of the Hydra transcatheter aortic heart valve in the treatment of symptomatic severe aortic stenosis in cardiac patients at high or extremely high surgical risk.
News | Heart Valve Technology
SMT announces positive results of Hydra Transcatheter Aortic Heart Valve published in JACC

February 14, 2022 — SMT (Sahajanand Medical Technologies Limited) has announced the publication of Hydra Transcatheter ...

Home February 14, 2022
Home
The American College of Cardiology will host the 71st Annual Scientific Session & Expo live, in person, in Washington, DC, April 2 – 4, 2022, and provides the opportunity to network with colleagues
Feature | ACC | By Melinda Taschetta-Millane
Keynote Speakers Announced for ACC 2022

The American College of Cardiology will host the 71st Annual Scientific Session & Expo live, in person, in Washington ...

Home February 11, 2022
Home
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced for the 2022 American College of Cardiology (ACC) meeting.
Feature | ACC | By Melinda Taschetta-Millane
ACC 2022 Late-breaking Clinical Trials Announced

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home February 10, 2022
Home
Northwestern Medicine McHenry Hospital recently achieved a milestone with the completion of the 100th Transcatheter Aortic Valve Replacements (TAVR).
News | Structural Heart
Northwestern Suburban Hospitals Celebrate 100th TAVR

Febraury 9, 2022 — Northwestern Medicine McHenry Hospital recently achieved a milestone with the completion of the 100th ...

Home February 09, 2022
Home
The Cardiovalve transcatheter mitral valve replacement (TMVR) technology for patients suffering from mitral or tricuspid regurgitation (MR and TR), is undergoing clinical trials in Europe.
News | Structural Heart
Technology Incubator Peregrine Ventures Exits Transcatheter Valve Company Cardiovalve

January 18, 2022 — Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare ...

Home January 18, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now